3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
8
Sarcopenia
2
Prostatic Neoplasms
2
Obesity
2
Melanoma
2
Malnutrition
2
Colorectal Neoplasms
2
Breast Carcinoma In Situ
2
Wound Infection
1
Weight Loss
1
Surgical Wound Infection
1
Skin Neoplasms
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Postoperative Complications
1
Polycystic Ovary Syndrome
1
Phagocyte Bactericidal Dysfunction
1
Pain
1
Paget's Disease, Mammary
1
Osteoarthritis
1
Olfaction Disorders
1
Neoplasms
1
Neoplasm, Residual
1
Mandibular Neoplasms
1
Lymphoma, Follicular
1
Lipid Metabolism Disorders
1
Huntington Disease
1
Fatigue
1
Diabetes Mellitus
1
Interventions
Nutrition Assessment
3
Metformin
3
Tablets
2
Resistance Training
2
Pioglitazone
2
Methods
2
Exercise
2
Educational Status
2
otelixizumab
1
nabiximols
1
Verapamil
1
Therapeutics
1
Surveys and Questionnaires
1
Specimen Handling
1
Risk Assessment
1
Remote Consultation
1
Pancreas, Artificial
1
Palliative Care
1
Lysine Acetyltransferase 5
1
Jogging
1
Interviews as Topic
1
Gastrectomy
1
Fish Oils
1
Endoscopic Mucosal Resection
1
Eating
1
Docosahexaenoic Acids
1
Diet, Mediterranean
1
Diet, Fat-Restricted
1
Diet, Carbohydrate-Restricted
1
DM199
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Diabetes Mellitus
×
Docosahexaenoic Acids
×
Clear all
NCT04116203
2025-02-28
PCOS
University of Alberta
Phase 1
Completed
52 enrolled